Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Aug 27, 2021 4:54pm
115 Views
Post# 33777185

RE:RE:RE:RE:RE:SPAC/SPCX/ETF's

RE:RE:RE:RE:RE:SPAC/SPCX/ETF's

Damnre, many would argue that the published science is already there and that is the reason that Boehringher made the huge offer in 2018 which was rejected at board of directors. A phase 1 MAD does not make 4050 any less efficacious in Alstrom or IPF but it was shut down. Lynn Gagnon and John Moran were the most credible people at PLI and absolutely swore by it as a wonder drug. It will come eventually what they had or did not have. Someone is lying right now and I don't think it's Moran or Gagnon 
 

 

Damnre wrote: Yes there is stuff that is not clear and shareholders are getting screwed. But lets take a look at the share numbers. With a 10m float If the company had any future this is nothing worth waisting time for the Thomsons.
They have money it's not in their advantage to fight about 10milion shares. They could just offer 10$ per share and most of the people will take it without hesitation.

The problem seems to be that they don't have anything, the science is not there anymore...scientinst that probably knew what they were doing left and that forced them to sell to kendrion.

I just hope that we as shareholder can recoup some of our money, and hope Thomsons take a look and at least try  hard to get it done. 10m Float is small and for a company on NASDAQ nothing... This can easy be bought on some good results and everybody would be happy.

 

stockbuphoon wrote: Fill you boots, my friend. I wish you luck but I see recent moves by management as strictly moves wanted by Thomson to devalue the company to zero as they have the IP. It's a little too convenient that they give away Ryplazim 2 weeks before approval and then shutdown 2 human trials for 4050 4 days before PDUFA date. If that is not intentional, I am not sure what is. They didn't release CRL letter for a year and it's all of a sudden important to suggest that 2 big indications have been dropped? Yet, the 4050 phase 1 MAD trials go on for another 7 months? Does no one else sense another debacle here at former house of PLI? 

inventors wrote: Ask Cantor Friz....last partner makes the rules....and their money helpped to bring us to this point,,,,,,

OR existing shareholders would have got zero...bancr't...?

I am still holding a pinch of leftovers, but bought in on some of the dips.

Today is like....pli @ 0.07/0.15/0.25...?

Load up man....lol.

 




<< Previous
Bullboard Posts
Next >>